Zorticos Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -99.96%
- Profit Growth 44.55%
- Ebitda 44.20%
- Total Assets %
About Zorticos Lifesciences
Zorticos Lifesciences Private Limited (ZLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2015 (Nine years and ten months 12 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sachinkumar Shukla, Prabhakar Bethi, and Vanithadevi Prabhakar serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51502MH2015PTC262873
- Company No.
262873
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Zorticos Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachinkumar Shukla  | Director | 20-Mar-2015 | Current |
| Prabhakar Bethi | Director | 20-Mar-2015 | Current |
| Vanithadevi Prabhakar | Director | 20-Mar-2015 | Current |
Financial Performance of Zorticos Lifesciences.
Zorticos Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 99.96% decrease. The company also saw a substantial improvement in profitability, with a 44.55% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zorticos Lifesciences?
In 2019, Zorticos Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zerico Lifesciences Private LimitedSachinkumar Shukla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zorticos Lifesciences?
Unlock and access historical data on people associated with Zorticos Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zorticos Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zorticos Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.